RUX may represent a valuable therapeutic option for some patients with advanced SR-aGVHD
Thats the best part.
Geeez.
Aloha.
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-263
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.008(0.57%) |
Mkt cap ! $1.501B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.436M | 1.104M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 16607 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 34620 | 10 |
View Market Depth
| Last trade - 14.56pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |